[From Research & Analysis to Manufacturing, DX, APIs, and Outsourcing] Japan's Largest Exhibition for Pharma, Cosmetics, and Biotech to be Held at Makuhari Messe in May

RX Japan will host Japan's largest pharmaceutical, cosmetics, and biotechnology exhibition at Makuhari Messe in May 2026.
NQ 56/100

📋 Article Processing Timeline

  • 📰 Published: March 29, 2026 at 18:39

RX Japan Ltd. (Headquarters: Chuo-ku, Tokyo; President and CEO: Takeshi Tanaka) will hold the "28th INTERPHEX Week Tokyo" at Makuhari Messe for three days from May 20 (Wed) to May 22 (Fri), 2026.
Marking its 28th edition, this year's event will feature a change in schedule and venue, moving to May at Makuhari Messe.

INTERPHEX Week is one of Japan's largest exhibitions covering R&D, analysis, manufacturing, quality control, packaging, outsourcing, and DX in the pharmaceutical, cosmetics, and biotechnology sectors. Pharmaceutical and cosmetics manufacturers, research institutions, and biotech-related companies from around the world will attend to engage in practical business negotiations through the latest technology and live equipment demonstrations.

■ 6 Specialized Exhibitions + Regenerative Medicine EXPO

The event consists of six specialized exhibitions.

These include INTERPHEX JAPAN, specializing in pharmaceutical manufacturing and packaging technology; INPHARMA JAPAN, focusing on APIs, intermediates, additives, and contract synthesis services; BioPharma EXPO, dedicated to biopharmaceutical research and manufacturing technology; PharmaLab EXPO, featuring the latest equipment for pharmaceutical R&D; and Pharma DX EXPO, a specialized exhibition solving DX challenges in the pharmaceutical industry.

Additionally, this year we are launching a new specialized exhibition: CMO / CDMO EXPO, themed around contract development and manufacturing for pharmaceuticals. Against the backdrop of government policies to strengthen drug discovery capabilities, improve the international competitiveness of the pharmaceutical industry, and reinforce supply chains, the strategic use of CMOs/CDMOs is gaining attention. This exhibition was established in response to strong demand from visiting pharmaceutical manufacturers.

Furthermore, the Regenerative Medicine EXPO, where research and manufacturing technologies for regenerative medicine and cell therapy are showcased, will be held concurrently.

■ 950 Companies Exhibiting Featured Products, Plus 320 Seminars

This year, 950 companies will exhibit, allowing attendees to compare and evaluate the latest equipment and new products. International participation is also increasing, with exhibitors confirmed from 25 countries and regions, including the U.S., Europe, China, South Korea, and Taiwan. The exhibition covers the entire industry, from pharmaceutical raw materials to R&D, manufacturing, quality control, and logistics. A wide range of products will be on display, from the latest research equipment and manufacturing facilities to production DX solutions and sustainable packaging. For researchers and engineers at pharmaceutical manufacturers, this event offers hints and solutions to help solve their challenges.